Kawakami, J. and Morales, A. (2013) “Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists”, Canadian Urological Association Journal, 7(3-4), pp. e226–30. doi: 10.5489/cuaj.540.